Management of the overdose of paliperidone 3-monthly injection: A case report

被引：0
|
作者：
Jin, Fei Xue [1 ]
Malik, Asad [2 ]
机构：
[1] Northern Sydney Local Hlth Dist, Sydney, NSW, Australia
[2] Napean Blue Mt Older Persons Mental Hlth Serv, Kingswood, NSW, Australia
来源：
AUSTRALASIAN PSYCHIATRY | 2023年 / 31卷 / 03期
关键词：
D O I：
10.1177/10398562231162233
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：405 / 405
页数：1
相关论文
共 50 条
  • [31] Paliperidone Palmitate 3-Monthly Versus 1-Monthly Injectable in Patients With Schizophrenia With or Without Prior Exposure to Oral Risperidone or Paliperidone: A Post Hoc, Subgroup Analysis
    Mathews, Maju
    Pei, Huiling
    Savitz, Adam
    Nuamah, Isaac
    Hough, David
    Alphs, Larry
    Gopal, Srihari
    CLINICAL DRUG INVESTIGATION, 2018, 38 (08) : 695 - 702
  • [32] Effectiveness and Quality of Life with Paliperidone Palmitate 3-Monthly in Comparison with Other Long-Acting Drugs
    Di Lorenzo, Rosaria
    Iorio, Anita
    Pinelli, Margherita
    Magarini, Federica
    Marchi, Mattia
    Sacchetti, Andrea
    Calogero, Chiara
    Galeazzi, Gian Maria
    Ferri, Paola
    Rovesti, Sergio
    Minarini, Alessandro
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2022, 18 : 829 - 846
  • [33] Symptomatic Remission and Functional Recovery after Paliperidone Palmitate 3-monthly or 1-monthly treatment in Asian Patients with Exacerbated Schizophrenia
    Savitz, Adam
    Xu, Haiyan
    Gopal, Srihari
    Nuamah, Isaac
    Hough, David
    Mathews, Maju
    Feng, Yu
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 242 - 243
  • [34] Acute Renal Failure After Paliperidone Overdose A Case Report
    Liang, Chih-Sung
    Bai, Ya-Mei
    Liou, Ying-Jay
    Chou, Yuan Hwa
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (01) : 128 - 128
  • [35] Determinants of Caregiver Burden in Family Carers of Asian Patients with Schizophrenia treated with Paliperidone Palmitate 3-monthly injectable
    Gopal, Srihari
    Xu Haiyan
    Savitz, Adam
    Nuamah, Isaac
    Woodruff, Kimberly
    Mathews, Maju
    Lu Yu
    Zhuo Jianmin
    Feng Yu
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 234 - 235
  • [36] Effects of Long-acting Injectable 3-Monthly Paliperidone Palmitate on the Clinical and Social Performance of Patients with Schizophrenia
    Oh, Jihoon
    Oh, Jihye
    Kim, Dong Wook
    Youn, HyunChul
    Kim, Sae-Hoon
    Kim, Soo In
    Chung, In Won
    Wang, Kuan Shu
    Kim, Minah
    Paik, Jong -Woo
    Koh, Min Jung
    Lee, Yoosun
    Choi, Seok Young
    Kim, Jung-Jin
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2023, 21 (01) : 126 - 134
  • [37] Stable schizophrenia patients switched to paliperidone palmitate 3-monthly formulation in real life: impact on caregiver burden
    Maina, G.
    Garcia-Portilla, M. P.
    Llorca, P. M.
    Bozikas, V. P.
    Devrimci-Ozguven, H.
    Kim, S. W.
    Bergmans, P.
    Strulev, V.
    Cherubin, P.
    Pungor, K.
    EUROPEAN PSYCHIATRY, 2019, 56 : S262 - S262
  • [38] Stable schizophrenia patients switched to paliperidone palmitate 3-monthly formulation in real life: functioning and resource use
    Garcia-Portilla, P.
    Llorca, P. M.
    Maina, G.
    Bozikas, V. P.
    Devrimci-Ozguven, H.
    Kim, S. W.
    Bergmans, P.
    Usankova, I.
    Cherubin, P.
    Pungor, K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S238 - S239
  • [39] Comparison of 3-Monthly versus 1-Monthly Paliperidone Palmitate for Time to Onset and Time to Resolution of Extrapyramidal Symptoms in Patients with Exacerbated Schizophrenia
    Mathews, Maju
    Nuamah, Isaac
    Savitz, Adam
    Hough, David
    Najarian, Dean
    Kim, Edward
    Gopal, Srihari
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 198 - 198
  • [40] Comparison of 3-Monthly versus 1-Monthly Paliperidone Palmitate for Time to Onset and Time to Resolution of Extrapyramidal Symptoms in Patients with Exacerbated Schizophrenia
    Mathews, Maju
    Nuamah, Isaac
    Savitz, Adam
    Hough, David
    Najarian, Dean
    Kim, Edward
    Gopal, Srihari
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 352S - 353S
12345